You Searched For "anti trust lawsuit on generic drug companies" and got 19 results
Sort By:
A frightening new book on the safety of generic drugs could send India’s pharma industry into an even deeper pit
Drug makers in India have relied on Americans to buy a big chunk their produce for a long time now…
A massive lawsuit just erased $2.5 billion from drug giant Teva's market cap. Here's how much Teva and rival drugmaker Mylan could stand to lose in court.
Those drugs included treatments for cancer, HIV and more, with price increases in some cases of mor…
Emma Court
20 state attorneys general are suing 6 generic drugmakers over collusion and price fixing
Heritage Pharmaceuticals' former president Jason Malek and former CEO Jeffrey Glazer were charged w…
Lydia Ramsey
A lawsuit over price fixing by drugmakers is being massively expanded
"We allege in this complaint that the defendant companies' collusion was so pervasive that it essen…
Lydia Ramsey
Bernie Sanders slams 'polite f-u' letters sent by generic drug companies as 'clearly illegal' and calls for an investigation
The Justice Department brought charges against two generic drug executives in late 2016, alleging t…
Emma Court
Trading intel with rivals and searching for 'dirt': Inside the secret communications that allegedly show how big drug companies plotted for years to increase the price of your medicines
The latest complaint has a similar focus on generic drugs and names a similar group of generic drug…
Emma Court
A smiley-face text message about hiking the price of an old drug is at the center of a massive lawsuit being brought against nearly 20 big drug companies
In a statement to Business Insider, Heritage said that it fired its former president and CEO in 201…
Emma Court
A huge lawsuit accuses nearly 20 big drug companies, a billionaire and two brothers-in-law of cozying up to hike drug prices. Here's the inside story.
In a statement to Business Insider, Heritage said that it fired Malek and Glazer in 2016 after an i…
Emma Court
Inside the secret messages that allegedly show how big drug companies plotted to increase the price of your medicines
The lawsuit is the second to be brought as part of an investigation by the states into generic drug…
Matt Turner
Federal judge bans Martin Shkreli from the pharmaceutical industry for life, orders him to pay $64.6 million fine
The so-called "Pharma Bro" was sued in early 2020 for an alleged antitrust violation over the price…
Jake Epstein
The makers of insulin are being accused of price-fixing in a class-action lawsuit
The complaint filed in the US District Court of Massachusetts details examples of patients who pay …
Lydia Ramsey
Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill
Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment c…
USFDA has set a new record in generic drug approvals this year-- but Indian drug makers have a lot to gain and little to lose
The American drug regulator approved 953 new generic drugs between October 2018 and June 2019. T…
A drug giant just got fined £37 million for 'illegal behaviour'
These 'pay-for-delay' agreements deferred the competition that the threat of independent generic en…
Oscar Williams-Grut
Ranbaxy Sues US FDA For Withdrawing Approval For Its Drugs
In its petition, Ranbaxy said that the FDA had exceeded its jurisdiction by revoking the approvals …
'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe
"The opposite is true. Allergan is committed to vigorously defending the intellectual property that…
Lydia Ramsey
Generic drugs are America's solution to high branded drug prices. But recent events suggest the market's not working
The other side: "For the most part, there's so much competition that the sustainability of the indu…
Caitlin Owens, Axios
Generic drugs work as well as brand-name drugs - here's why they're cheaper
Generic drugs are the same as brand name drugs in terms of ingredients, safety, and effectiveness. …
Sanjana Gupta,Jason McKnight
Amarin plummets 31% after appeal hearing related to its heart drug is 'incrementally negative,' analyst says to not buy shares
The hearing was "incrementally negative" for Amarin and gave no confidence that Amarin will prevail…